Anne-Marie Kanstrup Fiehn

11PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical mycologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 05, 2026
Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trial.

|Nov 22, 2025
Prognostic value of manual and digital PD-L1 expression in pT3 and pT4 colon cancer.

Dea Natalie Munch Jepsen, Marianne Bøgevang Jensen, Astrid Louise Bjørn Bennedsen

|Jan 19, 2023
The risk of lymph node metastasis in patients with T2 colon cancer.

Morten F Hartwig, Lasse Slumstrup, Anne-Marie Kanstrup Fiehn

|Jan 01, 2023
Risk factors for lymph node metastasis in patients with pT2 colon cancer in Denmark from 2016 to 2019-A nationwide cohort study.

Morten Hartwig, Andreas Rosen, Rasmus Vogelsang

|Feb 25, 2022
Use of Patient-Derived Organoids as a Treatment Selection Model for Colorectal Cancer: A Narrative Review.

Sara Furbo, Paulo César Martins Urbano, Hans Henrik Raskov

Pageof 2